Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
PHASE2
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Completed
Location
Hollings Cancer Center at Medical University of South Carolina
A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
PHASE1
This is an open multicenter randomized phase I/II study. The main purpose w...